A Randomized Phase III Study of Sublobar Resection versus Stereotactic Ablative Radiotherapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer
PIs: Hiran C. Fernando, M.D.
Thoracic/General Surgery, Boston Medical Center
Robert Timmerman, M.D.
Radiation Oncology, UT Southwestern Medical Center
The Joint Lung Cancer Trialist's Coalition would like to acknowledge support from Varian Medical Systems, Accuray and Elekta. The program is administered by the Department of Radiation Oncology at UT Southwestern Medical Center.